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Summary
Salmonella Typhimurium isolate D23580 represents a
recently identified ST313 lineage of invasive non-
typhoidal Salmonellae (iNTS). One of the differences
between this lineage and other non-iNTS S. Typhimu-
rium isolates is the presence of prophage BTP1.
This prophage encodes a gtrC gene, implicated in
O-antigen modification. GtrCBTP1 is essential for main-
taining O-antigen length in isolate D23580, since a
gtrBTP1 mutant yields a short O-antigen. This pheno-
type can be complemented by gtrCBTP1 or very closely
related gtrC genes. The short O-antigen of the gtrBTP1
mutant was also compensated by deletion of the BTP1
phage tailspike gene in the D23580 chromosome. This
tailspike protein has a putative endorhamnosidase
domain and thus may mediate O-antigen cleavage.
Expression of the gtrCBTP1 gene is, in contrast to
expression of many other gtr operons, not subject to
phase variation and transcriptional analysis suggests
that gtrC is produced under a variety of conditions.
Additionally, GtrCBTP1 expression is necessary and suf-
ficient to provide protection against BTP1 phage infec-
tion of an otherwise susceptible strain. These data are
consistent with a model in which GtrCBTP1 mediates
modification of the BTP1 phage O-antigen receptor in
lysogenic D23580, and thereby prevents superinfec-
tion by itself and other phage that uses the same
O-antigen co-receptor.
Introduction
Salmonella enterica subspecies enterica (S. enterica) is
responsible for 98% of human infections caused by Sal-
monella. Over 1500 serovars of S. enterica are recognized
in the Kaufman–White scheme (Grimont and Weill, 2007),
which uses differences in the O-antigen of the lipopolysac-
charide (LPS) and flagellar H antigen to differentiate
between isolates. Over 120 serovars are recognized as
having the group O4 O-antigen (Grimont and Weill, 2007),
which is characterized specifically by an abequose moiety
linked to the mannose with a 1–3 linkage (Reeves, 1993).
This is a subgroup of the O12 positive isolates that have an
O-antigen subunit backbone consisting of mannose, rham-
nose and galactose. Salmonella enterica subspecies
enterica serovar Tyhimurium, hereafter referred to as
S. Typhimurium, is one of these O4 (previously group B)
serovars.
Salmonella Typhimurium is a non-host-restricted
serovar typically associated with localized gastrointestinal
infection in humans. However, there is an epidemic of
invasive S. Typhimurium infections in Sub-Saharan Africa
predominantly associated with the novel multilocus
sequence type, ST313 (Kingsley et al., 2009; Okoro et al.,
2012). It is hypothesized that the immunocompromised
status of the population allowed evolution of these
strains since it can be traced to follow the spread of HIV
and is currently not commonly found outside of Africa
(MacLennan et al., 2010; Okoro et al., 2012). Sequencing
of a representative ST313 isolate, S. Typhimurium
D23580, identified several pseudogenes compared with
other S. Typhimurium isolates. Many of these are shared
with the host-restricted S. Typhi (Holt et al., 2008), which
could suggest that D23580 is becoming more host
restricted. An additional differentiating feature is the dis-
tinct repertoire of five prophage-like elements in the
D23580 genome (Kingsley et al., 2009). One of these is the
BTP1 prophage, and it was recently determined that this
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prophage carries glycosyltransferase (gtr) genes that con-
stitute a putative O-antigen modification operon (Davies
et al., 2013).
The O-antigen-modifying gtr operons have been found
in phage genomes, on prophages within Salmonella
genomes and in the context of phage remnant sequences
(Vernikos and Parkhill, 2006; Davies et al., 2013). The
gtr operons described to date consist of three genes: gtrA,
gtrB and gtrC. Based on biochemical analysis of P22
mediated O-antigen modification (Makela, 1973) and
related gtr operons in Shigella flexneri, it is hypothesized
that GtrA and GtrB add the glucose to a carrier lipid and flip
it to the periplasm, where the GtrC protein performs the
modification while the O-antigen side chain is being
assembled (reviewed in Allison and Verma, 2000). Phylo-
genetic mapping of the GtrC proteins showed that there are
at least 10 different ‘families’ of gtr operons in S. enterica
genomes (Davies et al., 2013), and individual strains can
encode for as many as four different gtr operons. It is
thought that each family is responsible for a unique
modification. Furthermore, the expression of many gtr
operons is under the control of epigenetic phase variation
(Broadbent et al., 2010a). Thus, the gtr repertoire of an
isolate with four phase-varying gtr operons could result in
up to 16 individual phenotypes within a population based
just on the O-antigen composition.
Of the 10 GtrC families identified in Davies et al., the
biochemical activity has been identified for only two,
family 1 GtrC (serotype O1) and family 3 GtrC (serotype
O122). Specifically, the phage P22 family 1 gtrC operon
results in the addition of a glucose residue via an α1– > 6
linkage to the galactose of the O-antigen subunit and the
O1 serotype (Fukazawa and Hartman, 1964; Makela,
1973; Van der Byl and Kropinski, 2000). Recently, the
factor O122 modification was attributed to a gtr operon
from family 3, which mediates addition of a glucose
molecule to the galactose via an α1– > 4 linkage
(Bogomolnaya et al., 2008). However, since the expres-
sion of both are under the control of phase variation, the
associated factor O1 and O122 modifications will not
always be detectable (Broadbent et al., 2010a). To date,
the activity of the remaining families of GtrC proteins has
not been elucidated.
There is evidence that the Gtr-mediated modification
helps prevent superinfection by altering the O-antigen
(co)-receptor recognized by the phage, which provides a
rationale for the presence of these genes on phage
genomes. The P22 tailspike protein (TSP) contains endor-
hamnosidase activity to cleave the O-antigen and better
gain access to the bacterial surface. This is blocked by
α1–6 glucosylation of the galactose in the O-antigen
subunit (O1 serotype), which is mediated by the P22 gtr
operon. The rhamnosidase activity is not blocked by the
chromosomally encoded family 3 gtr operon that results in
α1–4 glucosylation (O122 serotype). In contrast, phages
9NA and KB1 are able to cleave O-antigen containing the
α1–6 glucosylation but not the α1–4 glucosylation, so
there is some difference in the glycanase activity of dif-
ferent phages. P22 infection is also blocked by acetylation
of the rhamnose (Wollin et al., 1987). More recently, the
phase variable expression of the O122 modification was
demonstrated to directly affect the ability of phage SPC35
to infect S. Typhimurium (Kim and Ryu, 2012).
Many gtr operons have been retained in the genome of
Salmonella serovars despite the degradation of the sur-
rounding phage sequences (Davies et al., 2013). This
indicates that these operons may provide some addi-
tional, direct benefit for the bacterium. Indeed, in S. flex-
neri, glucosylation by the products encoded in the gtrV
operon increases virulence of the strain by compacting
the O-antigen layer to allow the type 3 secretion system
better access to epithelial cells (West et al., 2005). In
S. Typhimurium, the family 3 gtr-mediated glucosylation of
the O-antigen is associated with an increase in the per-
sistence of the bacteria in the intestine (Bogomolnaya
et al., 2008).
The gtr operon encoded by BTP1 is classified as a
family 2 gtr operon (Davies et al., 2013); this family is
associated with invasive Salmonella serovars, such as S.
Typhi and S. Paratyphi A. D23580 was the first S. Typh-
imurium isolate in which a family 2 gtr operon was iden-
tified, which suggests that the modification performed by
this operon may have contributed to the invasive capacity
of this invasive non-typhoidal Salmonellae (iNTS) isolate.
In this study we examined the functionality and signifi-
cance of the prophage-encoded gtrBTP1 present in the
iNTS strain D23580.
Results
The gtrBTP1 operon is required for full length of O-antigen
in iNTS strains with BTP1 prophage
To assess the role of the family 2 gtrBTP1 operon
(STMMW_03911–03921), these two genes were deleted
and introduced into the native BTP1 prophage in S. Typh-
imurium D23580 (sMV189), resulting in ΔgtrBTP1 (sMV386).
The LPS was analyzed on a sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) gel to
determine if a shift could be observed that would be
indicative of addition of a sugar moiety (Davies et al.,
2013). Unexpectedly, the O-antigen of this ΔgtrBTP1 strain
was very short (Fig. 1A, lane 2). The O-antigen of the
ΔgtrBTP1 strain differs from that of a mutant in the wzz gene,
which is responsible for producing the long O-antigen
chain length; this difference is especially evident in the
range of 5–9 O-antigen subunits (Fig. 1A, lane 2 vs. 4). The
ΔgtrBTP1 LPS phenotype also differed from a rough strain
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that lacks an O-antigen (data not shown). This indicates the
gtrBTP1 mutation did not affect the core LPS and O-antigen
biosynthesis pathways, and the reduced O-antigen length
is due specifically to the absence of gtrBTP1. The short
O-antigen phenotype was complemented by the cloned
gtrBTP1 operon (sMV359) as well as by the family 2 gtr
operon from S. Enteritidis PT4 (referred to as SEN-F2;
sMV338); the GtrCSEN-F2 protein shares 77% identity with
GtrCBTP1. However, complementation with the family 1
phage P22 gtr operon (sMV531) only partially restored the
amount of long O-antigen (Fig. 1B).
GtrCBTP1 does not require GtrA/B for activity
Comparative genome analysis showed that family 2 gtr
operons differed from other gtr operons due to the pres-
ence of a truncation of the gtrB gene (Davies et al., 2013).
Analysis of specifically the gtrBTP1 family 2 operon identi-
fied additional differences. First, gtrBTP1 has a complete
gtrB gene deletion, unlike the C-terminal gtrB truncation
found in other family 2 gtr operons (Davies et al., 2013).
Second, gtrABTP1 (referred to further as gtrA*) has a pre-
mature stop codon at nt 276 of the coding sequence,
compared with one at nt 390 in the S. Typhi and S.
Enteritidis family 2 gtr operons.
The mutations associated with the gtrBTP1 operon
suggest that the GtrA/B proteins are no longer necessary
for the activity of GtrC. Indeed, the ΔgtrBTP1 short O-antigen
phenotype can be complemented by providing just
GtrCBTP1 in trans (Fig. 2, lane 3). However, another possi-
bility is that GtrA/B complementation occurs from one of
the other chromosomal gtr operons. This is conceivable
since the amino acid sequence identity of GtrA and GtrB
between different gtr families is high, and the D23580
chromosome codes for family 3 and family 4 gtr operons in
addition to gtrBTP1 (Davies et al., 2013). To address the
necessity of GtrA/B for GtrCBTP1 functionality, a D23580
derivative with deletion of all three different gtr operons
was constructed (‘basal’ D23580 strain) (sMV688). In this
strain with an empty vector, the O-antigen is short (Fig. 2,
lane 4). Expression of long O-antigen is restored by com-
plementation with just GtrCBTP1 (Fig. 2, lane 5). This shows
that GtrCBTP1-dependent O-antigen modification does
not require any GtrA or GtrB proteins. Furthermore, this
Fig. 1. Deletion of the gtrBTP1 operon in S. Typhimurium D23580
affects O-antigen length. Crude LPS was run on a TSDS–PAGE
gel and silver stained (see Experimental procedures section).
Shown is LPS from stationary phase cultures of strain D23580 and
its derivatives grown in LB; each rung represents a 1 unit
difference in O-antigen length.
A. The O-antigen phenotype of the ΔgtrBTP1 mutant does not
resemble a wzz mutant. Lanes are as follows: (1) D23580; (2)
ΔgtrBTP1; (3) D23580; (4) wzz::kan.
B. Family 2 gtr operons complement the short O-antigen phenotype
seen in ΔgtrBTP1. Lanes are as follows: (1) ΔgtrBTP1 + pLAC22; (2)
ΔgtrBTP1 + pgtrBTP1; (3) ΔgtrBTP1 + pgtrSEN-F2; (4) ΔgtrBTP1 + pgtrP22.
SEN-F2 = S. Enteritidis family 2 gtr operon.
Fig. 2. GtrA and GtrB are not required for biological activity of
GtrCBTP1. LPS analysis details are as in legend for Fig. 1. Lanes are
as follows: (1) D23580; (2) D23580 ΔgtrBTP1 + pLAC22; (3) D23580
ΔgtrBTP1 + pgtrCBTP1; (4) basal D23580 + pLAC22; (5) basal
D23580 + pgtrCBTP1.
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indicates a mechanistic difference between modification
by family 2 GtrC proteins and GtrC proteins from families
with conserved gtrAB genes.
Identifying key features of the GtrCBTP1 protein
Alignment of the family 2 GtrC proteins with members of
GtrC family 1 or 3, which have documented glucosylation
activity, shows the former have a 33 amino acid con-
served region toward the N-terminus that is not shared
with the GtrC proteins from the other families (data not
shown). BLAST analysis showed that this region aligned
with the N-terminus of the S. Typhimurium O-antigen
acetyltransferase OafA, and also contains the RXXR motif
that is required for Oac-dependent acetylation of the
O-antigen in S. flexneri (Thanweer and Verma, 2012)
(Fig. 3A). A site-directed mutant in the RXXR motif was
generated to determine if this region was also important
for GtrCBTP1 activity; the R71A/R74A mutation of the
GtrCBTP1 protein (sMV648) failed to complement the short
O-antigen phenotype of the ΔgtrBTP1 strain (Fig. 3B, lane
4). This mutant GtrC protein is still expressed and can be
detected in the membrane at levels similar to wild-type
GtrC (Fig. 3C). These data show that the RXXR motif is
required for GtrCBTP1 activity, in the same way as it is
required for Oac acetylation in S. flexneri.
GtrCBTP1 distinguishes itself from S. flexneri Oac, first,
by being in the context of a (remnant) gtr operon. Second,
topological analysis demonstrated that Oac has 10 trans-
membrane domains and a C-terminal cytoplasmic domain
(Thanweer and Verma, 2012), whereas GtrCBTP1 is pre-
dicted to have 11 transmembrane domains and a 273
amino acid long C-terminus in the periplasm (Fig. 4A). To
determine the localization of the RXXR motif and the
C-terminal domain, GtrCBTP1 protein topology was ana-
lyzed with PhoA protein fusions. The PhoA enzyme is only
active in the periplasm, so the location of loops between
transmembrane domains can be determined by assess-
ing the absence or presence of PhoA enzymatic activity in
strains containing these fusions. Five different fusions
were created (vectors pMV406-410) and PhoA activity
Fig. 3. The RXXR motif is required for GtrCBTP1 biological activity.
A. Family 2 GtrC proteins share homology with O-antigen
acetyltransferase Oac from S. flexneri (SF). The RXXR motif found
to be necessary for Oac activity is highlighted in the boxed region.
Alignment was performed using TCOFFEE. SEN = S. Enteritidis;
F2 = Family 2 GtrC.
B. LPS analysis as in legend for Fig. 1. Lanes are as follows: (1)
D23580; (2) ΔgtrBTP1 + pLAC22; (3) ΔgtrBTP1 + pgtrCBTP1; (4)
ΔgtrBTP1 + pgtrC(R71/74A)BTP1; (5) D23580.
C. Membrane localization of FLAG-tagged GtrCBTP1 and its
R71A/R74A mutant derivative. Shown is a Western blot probed with
anti-FLAG of WCL (top) and crude membrane extracts (bottom)
made from D23580 ΔgtrBTP1 containing indicated vectors. Lanes: (1)
pLAC22; (2) ΔgtrBTP1 + pgtrCBTP1; (3) ΔgtrBTP1 + pgtrC(R71/74A)BTP1.
Fig. 4. Membrane topology of GtrCBTP1 and requirement for the
C-terminal periplasmic domain for activity.
A. Locations of the GtrCBTP1–PhoA fusions along the TMHMM
(Moller et al., 2001) topology prediction are given with an asterisk
(*). Dashes along top indicate 100aa increments.
B. Phenotype of GtrCBTP1–PhoA fusion in both E. coli and
S. Typhimurium (S. Tm) strain 4/74. (−) indicates white color and
(+) blue color. The location of the amino acid fusion is given in the
vector name along the top row.
C. The C-terminus of GtrCBTP1 is required for activity. LPS analysis
as in the legend for Fig. 1. Lanes are as follows: (1) D23580; (2)
ΔgtrBTP1; (3) gtrC(Δ402–640)BTP1.
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was investigated in both Escherichia coli and S. Typhimu-
rium. A fusion at amino acid 37, at the end of the first
predicted transmembrane domain, was PhoA-positive,
whereas fusions at amino acids 56 and 76 were PhoA-
negative; the latter two amino acids flank the RXXR loop,
indicating those essential amino acids are located in the
cytoplasm (Fig. 4B). In agreement with the topology pre-
diction, PhoA fusions at amino acids 370 (at the beginning
of the predicted C-terminal periplasmic region) and 640
(at the C-terminal end) resulted in PhoA-positive colonies,
indicating periplasmic localization. GtrCBTP1 activity fur-
thermore requires at least the final 238 amino acids of the
predicted 273 amino acid periplasmic C-terminus, as the
O-antigen of a strain with gtrCBTP1 truncated at amino
acid 402 (sMV548) resembles that of the ΔgtrBTP1 strain
(sMV386) (Fig. 4C). These data are consistent with the
long C-terminus of GtrCBTP1 being located in the periplasm
and having an essential role for the biological function of
the protein.
Taken together, the data described earlier suggest that
the family 2 gtr operon encodes an O-antigen acetyltrans-
ferase. First, there is no requirement for GtrAB proteins
that are necessary for glucose modification, and second,
the RXXR motif is essential, similar to the role of this motif
in S. flexneri O-antigen acetyltransferase Oac.
gtrCBTP1 expression is not phase variable
Expression of most gtr operons across the gtr families,
except family 4, is under the control of phase variation
associated with a signature sequence in the regulatory
region (Broadbent et al., 2010a; Davies et al., 2013). The
sequence upstream of gtrA* in BTP1, however, contains a
365 nucleotide sequence that disrupts this signature
sequence. To assess whether the insertion disrupts phase
variation, a strain carrying a fusion of this region from
gtrBTP1 to lacZ was analyzed. This strain gave rise to
colonies with a uniform Lac+ (ON) phenotype (data not
shown), reflecting a lack of phase variation.
Two transcriptional start sites (TSS) of gtrBTP1 were iden-
tified in strain D23580 by differential RNA-seq analysis.
One TSS was upstream of gtrA*, and the second upstream
of gtrCBTP1 (Fig. 5A). The former is the same TSS previ-
ously identified for the gtrLT2_I operon (STM0559-7) in
S. Typhimurium strain LT2 that is phase variable
(Broadbent et al., 2010b). However, as shown earlier, in
strain D23580, transcription from this promoter region is
not controlled by phase variation. The second TSS is in a
region created by the gtrB deletion in D23580 and presum-
ably would not be present in other gtr operons. Transcrip-
tomic data from RNA-seq experiments (Fig. 5B) indicate
Fig. 5. Genetic organisation and transcriptional profiling of the gtrBTP1 locus. The gtrA*, gtrC and STMMW_03901 (TSP) genes are encoded
within the phage BTP1 locus in S. Typhimurium strain D23580 (Kingsley et al., 2009).
A. The locations of the transcription start sites (TSS) of gtrC (STMMW_03911) and gtrA* (STMMW_3921) are shown, and the predicted
-10/-35 promoter motifs and the initiating nucleotide of both gtr transcripts are highlighted in bold. The nucleotide position of the gtrC
(STMMW_03911) gene is 406441–408363 (negative strand), the gtrA* (STMMW_3921) gene is 408435–408710 (negative strand) and the
STMMW_03901 gene is 404416–406401 (positive strand) on the D23580 chromosome.
B. Absolute gene expression of the gtrBTP1 locus. The heat map shows the levels of gene expression of the gtrBTP1 genes as TPM values,
derived as described (Kroger et al., 2013).
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that both gtrA* and gtrCBTP1 are usually expressed, and
therefore a degree of O-antigen modification is likely to
occur, under a wide range of growth conditions. These
ranged from standard laboratory growth conditions to
those designed to mimic in vivo infections (Kroger et al.,
2013; see Experimental procedures section for further
details). Future work is needed to determine the relative
contribution of the two promoters for gtrCBTP1 expression.
The ΔgtrBTP1 effect on O-antigen length requires the
BTP1 phage tailspike protein
Analysis of the sequence adjacent to the gtrBTP1 operon
identified gene STMMW_03901, which is convergently
transcribed (see Fig. 5A). STMMW_03901 encodes for a
TSP with 70% identity to that of the well-studied Salmo-
nella phage P22 protein. The phage P22 TSP has
endorhamnosidase activity that allows cleavage of the
O-antigen. Specific amino acids important for this enzy-
matic activity of P22 TSP (namely, Glu 359, Asp 390 and
Asp 392) are present in BTP1 TSP (Baxa et al., 1996;
Steinbacher et al., 1996). Thus, the shorter O-antigen of
the ΔgtrBTP1 strain could be due to BTP1 TSP-dependent
cleavage of full length O-antigen.
This hypothesis was tested by deleting the TSP gene in
the D23580 ΔgtrBTP1 mutant (Fig. 6). When the ΔgtrBTP1
mutation is combined with the TSP deletion, the same full
length O-antigen is seen as in the wild-type strain (Fig. 6,
lane 3). This correlation between O-antigen length,
depending on the presence of gtrCBTP1 and the TSP with
its associated rhamnosidase activity, held true for two
other iNTS strains (5597 and A38596) that are phyloge-
netic relatives of D23580 and harbor the BTP1 prophage
(Kingsley et al., 2009; Okoro et al., 2012) (Fig. 6, lanes
4–9). These data lead us to conclude that in wild-type
D23580, GtrCBTP1 acts to protect the O-antigen from
cleavage by the phage BTP1 tailspike-encoded rhamnosi-
dase activity.
Significance of GtrCBTP1 in phage–bacteria interactions
The findings described earlier are consistent with a model
in which prophage-encoded GtrCBTP1 mediates O-antigen
modification, possibly via acetylation. Modification of a
receptor is a common phage strategy to protect a lysogen
from superinfection by phages that use the same (co)-
receptor, in this case the O-antigen. Phage P22 is known
to bind O-antigen as a receptor via its TSP and the BTP1
TSP sequence is homologous to that of P22 (Steinbacher
et al., 1997), suggesting that BTP1 may also use the
O-antigen as a (co)-receptor. Furthermore, our data indi-
cate that unmodified, full-length O-antigen on the cell
surface can be cleaved by the BTP1 phage TSP similar to
P22 (Steinbacher et al., 1997), which can facilitate phage
penetration.
In this model, the short O-antigen of the ΔgtrBTP1 strain
is a result of BTP1 phage-dependent O-antigen cleavage
and, therefore, free phage BTP1 particles should be
present in cultures of strain D23580. Indeed, plaques are
observed upon spotting supernatant of a culture of strain
D23580 on a lawn of ‘basal’ LT2, which is a mutant that
lacks both native gtr operons (Fig. 7A). No plaques were
observed with the supernatant of a D23580 mutant that
has the BTP1 TSP gene deleted from the prophage, indi-
cating these plaques are derived from BTP1 phage and
not from other prophage present in this strain (Fig. 7A)
(Kingsley et al., 2009). Furthermore, culture supernatants
from the D23580-related iNTS strains A130 and A38596
also showed plaque formation, indicative of free BTP1
phage (data not shown).
To examine whether the GtrCBTP1 O-antigen modification
affects phage susceptibility, spot titer tests were carried out
with the BTP1- and P22-containing supernatants. Plaque
formation by these phages was tested against the basal
LT2 strain either with or without GtrCBTP1, and against
wild-type D23580 and the ΔgtrBTP1 mutant. As expected, no
plaque formation occurs on a D23580 lawn, consistent with
an active phage repressor system. Interestingly, some P22
plaques did form on the ΔgtrBTP1 mutant, suggesting that
P22 is a heteroimmune phage (right column, Fig. 7B).
Importantly, GtrCBTP1 activity blocked infection by both
phages BTP1 and P22 (Fig. 7B). Specifically, BTP1 and
P22 formed plaques on the basal LT2 strain containing only
Fig. 6. O-antigen length in iNTS strains with the BTP1 prophage
is defined by a combination of the TSP rhamnosidase and GtrCBTP1
activity. LPS analysis as in legend for Fig. 1. Lanes are as follows:
(1) D23580; (2) D23580 ΔgtrBTP1; (3) D23580 ΔgtrBTP1ΔTSP; (4)
iNTS strain 5597; (5) 5597 ΔgtrBTP1; (6) 5597 ΔgtrBTP1ΔTSP; (7)
iNTS strain A38596; (8) A38596 ΔgtrBTP1; (9) A38596 ΔgtrBTP1ΔTSP.
WT = wild-type strain.
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empty vector (Fig. 7B). This plaque formation, however, is
absent when spotting BTP1 phage on this strain containing
pgtrCBTP1 (sMV816). Similarly, P22 infection of LT2 is
strongly inhibited by pgtrCBTP1 (Fig. 7B). P22 also does not
infect wild-type D23580 but can infect the ΔgtrBTP1 D23580
mutant. These data illustrate the protective nature of the
modification of the O-antigen by GtrCBTP1.
Importantly, both the BTP1 and P22 phages mediated
cleavage of the full length O-antigen present on basal LT2
(Fig. 7C, lanes 2 and 4). When the GtrCBTP1 protein was
present, O-antigen was not cleaved from the surface of
the bacteria and full length LPS was maintained (Fig. 7C,
lanes 6 and 8). No O-antigen cleavage was observed with
supernatant from the ΔgtrBTP1ΔTSP strain that lacks both
gtrBTP1 and TSP (Fig. 7C, lanes 3 and 7). Thus, GtrCBTP1
activity protects the O-antigen from BTP1 TSP mediated
O-antigen cleavage.
Another role of phage receptor modification could be the
prevention of readsorption of phage released by lysogenic
kin. To address whether GtrCBTP1-mediated O-antigen
modification can prevent readsorption, phage titers from
wild-type D23580 and the ΔgtrBTP1 mutant were compared
Fig. 7. GtrCBTP1 O-antigen modification
prevents infection by both P22 and BTP1 and
inhibits cleavage of the O-antigen by the
BTP1 phage.
A. Supernatant from D23580 cultures,
containing BTP1 phage, or the ΔgtrΔTSP
mutant were spotted on lawns of basal
LT2 + pLAC22.
B. Supernatant from cultures contacting BTP1
or P22 phage were spotted at equal titer
(about 3.5 × 105 pfu ml−1) on lawns of
wild-type D23580, the ΔgtrBTP1 mutant, basal
LT2 + pLAC22 or basal LT2 + pgtrCBTP1.
C. Cultures of basal LT2 containing either
empty vector or pgtrCBTP1 were incubated with
supernatant of cultures from strains (as
indicated along top of gel) to investigate
O-antigen cleavage from the surface. LPS
analysis performed as described in Fig. 1.
Fig. 8. Modification by GtrCBTP1 prevents
readsorption of phage.
A. BTP1 titer is reduced in a strain with a
deletion of gtrBTP1. Supernatants containing
BTP1 phage, obtained from a D23580 culture
or the ΔgtrBTP1 mutant, were spotted on lawns
of basal LT2. Dilutions from the original
supernatant are given.
B. BTP1 and P22 phage titers are affected by
adsorption with strains having or lacking
GtrCBTP1 O-antigen modification. BTP1 and
P22 phage were incubated for 5 minutes with
the indicated strains (top row shows phage
titer pre-adsorption). Bacteria and phage
bound to their surface were removed by
pelleting and the free, unadsorbed phage
numbers determined by spotting the
supernatant on a lawn of basal LT2. The
same dilution of phage for all samples is
shown.
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(Fig 8A). Phage concentrations produced by overnight
cultures of D23580 were 5.8 × 107 pfu/ml, but the ΔgtrBTP1
mutant only produced 1.4 × 106 pful/ml. The lower titers in
the absence of GtrCBTP1 could be due to phage particles
rebinding to the surface of the bacteria that express an
un-modified O-antigen. To further test adsorption directly,
BTP1 phage-containing supernatant was incubated with
the LT2 strain that lacks O-antigen modification, and
with this strain expressing GtrCBTP1 (Fig. 8B). Adsorption
with the unmodified strain resulted in a greater decrease in
titer than adsorption with the strain expressing modified
O-antigen. This is consistent with the conclusion that modi-
fication can reduce readsorption of phage. Less adsorption
to the LT2 strain with modified O-antigen was also
observed with P22 phage, consistent with the lower level of
infection observed on strains with GtrCBTP1-mediated
O-antigen modification (Fig. 7). Together, our data support
a model in which BTP1 phage-encoded GtrC modifies the
BTP1 O-antigen (co)-receptor to reduce superinfection by
heteroimmune phages that use the same O-antigen moiety
as BTP1 as co-receptor, and to limit readsorption by kin.
Discussion
The BTP1 prophage is one of the distinguishing genetic
features of the iNTS S. Typhimurium strain D23580
(Kingsley et al., 2009). Previously, a Salmonella-wide
genome analysis for the occurrence of O-antigen modify-
ing gtr operons determined that this prophage encoded an
uncharacterized gtr operon (Davies et al., 2013). Here we
analyzed the operon and its significance for this strain. This
gtr operon has one full-length protein: the GtrCBTP1 protein.
We determined that GtrCBTP1 has hallmarks consistent with
acetyltransferase activity. Expression of GtrCBTP1 occurs
under a wide range of growth conditions that are relevant to
infection, and, unlike many other gtr operons, expression
of gtrBTP1 is not subject to phase variation. We show that the
GtrCBTP1-mediated modification plays an important role in
the bacterium–phage interaction by protecting the bacte-
rium from infection by both BTP1 and the related P22
phage.
Previously characterized gtrABC operons mediate the
glucosylation of the O-antigen, but have different receiving
moieties and linkages (Allison and Verma, 2000). In con-
trast, our data suggest that the gtrBTP1 locus mediates
acetylation of the O-antigen, and we propose that GtrCBTP1
is the protein responsible for the acetylation of the rham-
nose residue in the O-2 and O-3 positions that was recently
identified in biochemical analysis of the O-antigen of strain
D23580 (Micoli et al., 2014). First, GtrCBTP1 contains an
acetyltransferase domain from the acyl_transf_3 super-
family within its first 360 amino acids. Second, we showed
that a RXXR protein motif that is essential for the Oac
acetyltransferase activity in S. flexneri (Thanweer and
Verma, 2012) is present in GtrCBTP1 and also is essential for
its activity (Fig. 3A and B). GtrA and GtrB have roles in
transferring a glucose moiety across the inner membrane;
the absence of gtrB and truncation of gtrA, and the fact they
are not required for this modification (Fig. 2), provides
further evidence that the activity of GtrCBTP1 does not
involve glucosylation.
All the data are consistent with the conclusion that the
family 2 GtrCBTP1 mediates acetylation of the rhamnose in
the O-antigen. Based on high amino acid identity among
the GtrC proteins of this family (Davies et al., 2013) and
the ability of the S. Enteritidis family 2 gtr operon to
complement the ΔgtrBTP1 short O-antigen phenotype, it is
highly likely that all family 2 GtrC proteins have acetyl-
transferase activity. In support of this conclusion, analysis
of the O-antigen of defined strains of S. Typhi confirmed
that acetylation of the rhamnose requires the S. Typhi
family 2 gtr operon (manuscript in preparation). This S.
Typhi GtrC has 77% identity with GtrCBTP1 and 99% iden-
tity with the S. Enteritidis family 2 GtrC protein, which
complements the short O-antigen phenotype of our
ΔgtrBTP1 mutant. Thus there is strong support for the con-
clusion that all family 2 GtrC proteins carry out acetylation
of the rhamnose in the O-antigen of these strains.
GtrCBTP1 and other O-antigen acetyltransferases, such
as Oac in S. flexneri and OafA in S. Typhimurium (Slauch
et al., 1996; Thanweer et al., 2008; Thanweer and Verma,
2012), share some predicted structural features. As noted
earlier, all three acetyltransferase proteins contain the
RXXR motif, which is necessary for the O-antigen modifi-
cation by Oac and GtrCBTP1. A cytoplasmic location of
this motif has been experimentally confirmed for Oac
(Thanweer et al., 2008) and GtrCBTP1 (Fig. 4), and is pre-
dicted for OafA (Thanweer and Verma, 2012). The three
acetyltransferases are also membrane proteins with mul-
tiple membrane spanning regions, ranging from 9 to 11
transmembrane domains. One of the significant differ-
ences between GtrCBTP1, OafA and Oac is the length and
location of the C-terminal soluble domain. GtrCBTP1 and
OafA contain a large (270 aa for GtrCBTP1, predicted 255 aa
for OafA) periplasmic tail that is necessary for activity
(Fig. 4C and Hauser et al., 2011). In contrast, Oac has a
relatively short (22 aa), cytoplasmically located C-terminal
end. The role and relevance of the location of the C-termini
remain to be elucidated, but it suggests that Salmonella
GtrC acetyltransferase enzymes have an additional activ-
ity or different mechanisms of activity than Oac from
S. flexneri.
For these O-antigen acetyltranferases, it is unclear from
where the acetyl moiety is derived, and where or when the
moiety is transferred to the growing O-antigen chain. Given
the requirement for both a cytoplasmic and a periplasmic
domain, and the presence of multiple transmembrane
domains, one possibility is that family 2 GtrC proteins
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function as a channel for the acetyl moiety in addition to
carrying out the enzymatic transfer reaction. In this model,
the RXXR cytoplasmic loop might be involved in binding
the acetyl group for transfer to the periplasm. Alternatively,
modification of the O-antigen subunit could occur in the
cytoplasm as has been proposed for OafA (Slauch et al.,
1996). The C-terminal domain may mediate necessary
protein–protein interactions, potentially with the O-antigen
assembly complex. Further work on the structure/function
relationship of Gtr proteins is needed to elucidate these
and many other aspects of gtr-mediated O-antigen
modification.
Acetylation of the O-antigen, and specifically of the
rhamnose moiety, has been previously described in
context of lysogenic conversion by phages A3 and A4
(Wollin et al., 1987). This modification inhibited P22
adsorption and it was inferred that TSP-mediated
O-antigen cleavage was inhibited (Wollin et al., 1987).
Similarly, our data indicate that P22 and BTP1 phage-
mediated infection is inhibited by GtrCBTP1 activity, likely
because the acetyl modification blocks the TSP endorham-
nosidase activity. This was evident from the short
O-antigen phenotype in the absence of GtrCBTP1, and the
dependency on the TSP for this phenotype. Effective pro-
tection against phage infection may also be facilitated by a
high level of acetylation, with an estimated 80% of
O-antigen subunits containing the modification in D23580
(Micoli et al., 2014). There are two contributing factors to
this high degree of modification. First, GtrCBTP1 expression
was not subject to phase variation, and thus all cells in a
population will have modified O-antigen. This is in contrast
to gtrP22-mediated glucosylation, for which the mixed popu-
lation generated by phase variation was directly shown to
affect the dynamics of interactions of a population of cells
with phage (Kim and Ryu, 2012). Second, the fact that
gtrA*C appears to be expressed in a wide range of growth
conditions suggests that the O-antigen will usually be in the
modified state (Fig. 5B). Thus, a benefit of the BTP1
prophage for the bacterium is that it confers effective
protection on the entire bacterial population against infec-
tion by BTP1 and both homo- and heteroimmune phages
that use the same O-antigen moiety as co-receptor.
There are several aspects of the BTP1 phage that could
potentially contribute to the virulence of iNTS BTP1 lyso-
gens. One is the high titer of BTP1 prophage (an average
of 7 × 107 pfu ml−1) we found in overnight cultures, even in
the absence of phage-inducing conditions. Phage-
associated lysis could produce bacterial debris, and this,
in turn, could affect the development of the immune
response to the iNTS infection. Additionally, the BTP1-
encoded family 2 gtrBTP1 operon is not under the control of
phase variation, whereas other family 2 operons are
phase variable, including those from S. Enteritidis and S.
Typhi and the majority of gtr operons (Broadbent et al.,
2010a). Thus, D23580 does not have the option for
phase-variable immune evasion from antibodies devel-
oped to the acetylated O-antigen, which could be signifi-
cant. However, whether acetyl modification affects the
course of infection has yet to be determined. The family 2
gtr operons are associated with many invasive serovars of
S. enterica, and it will be important to determine whether,
as we propose, O-antigen acetylation contributes to the
typical course of infection, including systemic disease, as
reported for the iNTS isolates.
Experimental procedures
Bacterial strains and culture conditions
Strains are listed in Table 1. Strains were maintained in either
Luria broth or on Luria–Bertani (LB) plates at 37°C. Strains
harboring temperature-sensitive vectors were grown at 30°C.
For selection of mutants or maintenance of vectors, the
following antibiotic concentrations were used: tetracycline
(15 μg ml−1), ampicillin (100 μg ml−1), chloramphenicol
(34 μg ml−1 for vectors or 8 μg ml−1 for chromosomal inserts)
or kanamycin (30 μg ml−1).
Molecular biology techniques
Standard molecular biology techniques were used
(Sambrook et al., 1987). DNA was obtained using either
genomic DNA isolated as described (Ausubel et al., 1989) or
Qiagen miniprep kit for plasmids. PCRs were performed
using either Merck’s KOD Hot Start (Billerica, MA, USA) or
Promega’s GoTaq Flexi polymerases (Madison, WI, USA).
Restriction enzymes and T4 ligase for cloning were
purchased from NEB (Ipswich, MA, USA). All vectors and
plasmids generated for this study are listed in Table 2. The
site-directed mutagenesis was performed on constructs
in the pLAC22 vector (Warren et al., 2000) with primers
oMV954 (GAATTTTACAAGAGAGCAATACTAGCAATATTC
CCAGCT) and oMV955 (AGCTGGGAATATTGCTAGTATTG
CTCTCTTGTAAAATTC) using Agilent’s QuikChange Light-
ning kit (Santa Clara, CA, USA). Bold regions indicate codons
changed to introduce the mutations.
Constructon of lacZ reporter fusions and detection of
LacZ activity
The CRIM system was used to insert gtr promoter–lacZ
fusions into the attB site of S. Typhimurium LT2 (Haldimann
and Wanner, 2001) using vector pMV243 (Broadbent et al.,
2010a). Strains containing inserts were streaked on minimal
M9 media agar plates containing 40 μg ml−1 X-gal (5-bromo-
4-chloro-3-indolyl-ß-D-galactoside) (Melford; Ipswich, Suffolk,
UK).
Generation of mutant strains
Allelic replacement was used to introduce mutations to the
chromosome (Datsenko and Wanner, 2000). Antibiotic resist-
ance cassettes were obtained from Tn10 for Tc-resistance
(TcR) and pKD13 for KmR. To generate multiple mutations in
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a single strain, these resistance cassettes were occasionally
removed (as indicated in Table 1) before the next mutation
was introduced. Since the pKD13 KmR cassette is flanked
by flippase recognition target (FRT) sites, the introduction of
pCP20 (Cherepanov and Wackernagel, 1995) or its pCP20-
TcR derivative allowed for the expression of Flp recombinase
to produce unmarked mutant strains. When the Tn10 TcR
cassette was used, lambda-red recombination was used to
introduce an oligonucleotide homologous to the region sur-
rounding the TcR cassette. This combined with counter-
Table 1. Strains used in this study.
Strain name in text Strain number Relevant genotype Plasmid Source
Escherichia coli isolates
E. coli–gtrC(37)BTP1–phoA MV1557 NEB5a pMV406 This study
E. coli–gtrC(56)BTP1–phoA MV1558 NEB5a pMV407 This study
E. coli–gtrC(76)BTP1–phoA MV1559 NEB5a pMV408 This study
E. coli–gtrC(370)BTP1–phoA MV1560 NEB5a pMV409 This study
E. coli–gtrC(640)BTP1–phoA MV1561 NEB5a pMV410 This study
Salmonella Typhimurium isolates
D23580 sMV189 Wild-type Kingsley et al., 2009
gtrABTP1–lacZ sMV523 sMV77att::pMV349 This study
ΔgtrBTP1 sMV386 D23580 ΔgtrBTP1
(STMMW_03921-STMMW_03911)
This study
Δwzz sMV664 D23580 wzz::kan (STMMW_21101) This study
ΔgtrBTP1 + pLAC22 sMV610 D23580 ΔgtrBTP1 pLAC22 This study
ΔgtrBTP1 + pgtrBTP sMV569 D23580 ΔgtrBTP1 pMV359 This study
ΔgtrBTP1 + pgtrSEN-F2 sMV571 D23580 ΔgtrBTP1 pMV338 This study
ΔgtrBTP1 + pgtrP22 sMV531 D23580 ΔgtrBTP1 pMV333 This study
ΔgtrBTP1 ΔTSP sMV800 D23580 ΔgtrBTP1 ΔTSP This study
ΔgtrBTP1 + pgtrCBTP1 sMV647 D23580 ΔgtrBTP1 pMV390 This study
ΔgtrBTP1 + pgtrC (R71/74A)BTP1 sMV648 D23580 ΔgtrBTP1 pMV392 This study
gtrC(Δ402–640)BTP1 sMV548 D23580 gtrC(402–640)BTP1::kan This study
S. Tm-gtrC(37)BTP1–phoA sMV697 S. Typhimurium 4/74 pMV406 This study
S. Tm-gtrC(56)BTP1–phoA sMV698 S. Typhimurium 4/74 pMV407 This study
S. Tm-gtrC(76)BTP1–phoA sMV699 S. Typhimurium 4/74 pMV408 This study
S. Tm-gtrC(370)BTP1–phoA sMV700 S. Typhimurium 4/74 pMV409 This study
S. Tm-gtrC(640)BTP1–phoA sMV701 S. Typhimurium 4/74 pMV410 This study
Basal D23580 sMV688 D23580 ΔoafA; ΔgtrBTP1; ΔgtrFam3; ΔgtrFam4 This study
Basal D23580 + pLAC22 sMV691 D23580 ΔoafA; ΔgtrBTP1; ΔgtrFam3; ΔgtrFam4 pLAC22 This study
Basal D2350 + pgtrCBTP1 sMV689 D23580 ΔoafA; ΔgtrBTP1; ΔgtrFam3; ΔgtrFam4 pMV390 This study
Basal LT2 + pLAC22 sMV815 LT2 ΔoafA; gtrFam3::tet; ΔgtrFam4::kan pMVLAC22 This study
Basal LT2 + pgtrBTP1 sMV816 LT2 ΔoafA; gtrFam3::tet; ΔgtrFam4::kan pMV390 This study
5597 sMV762 iNTS, lineage I Kingsley et al., 2009
5597ΔgtrBTP1 sMV796 5597 gtrBTP1::tet This study
5597ΔgtrBTP1ΔTSP sMV801 5597 gtrBTP1::tet;TSP::kan This study
A38596 sMV765 iNTS, lineage II Kingsley et al., 2009
A38596ΔgtrBTP1 sMV792 A38596 A38596 gtrBTP1::tet This study
A38596ΔgtrBTP1ΔTSP sMV802 A38596 gtrBTP1::tet; TSP::kan This study
A130 sMV761 iNTS, lineage I Kingsley et al., 2009
Table 2. Plasmids used in this study.
Parent plasmid Description; gene cloned with oligonucleotides used Source
pCP20-TcR pCP20 TcR cassette inserted into SmaI site of pCP20 [oMV466; oMV467]a This study
pMV349 pMV243 BTP1 regulatory region–lacZ fusion [oMV413; oMV875] This study
pMV333 pLAC22 gtrABC(P22) [oMV776; oMV778] Broadbent et al., 2010a
pMV338 pLAC22 gtrABC(S. Enteritidis family 2) [oMV776; oMV780] This study
pMV359 pLAC22 gtrABC(BTP1) [oMV897; oMV898] This study
pMV390 pLAC22 BTP1 GtrC-FLAG [oMV898; oMV958/959] This study
pMV392 pLAC22 BTP1 GtrC (R54A/R57A)-FLAG; [oMV954; oMV955] This study
pMV406 pSK4158 gtrC(BTP1)–phoA fusion at amino acid 37 [oMV993; oMV1003] This study
pMV407 pSK4158 gtrC(BTP1)–phoA fusion at amino acid 56 [oMV994; oMV1003] This study
pMV408 pSK4158 gtrC (BTP1)–phoA fusion at amino acid 76 [oMV995; oMV1003] This study
pMV409 pSK4158 gtrC (BTP1)–phoA fusion at amino acid 370 [oMV996; oMV1003] This study
pMV410 pSK4158 gtrC (BTP1)–phoA fusion at amino acid 640 [oMV997; oMV1003] This study
a. Oligos are given in Supplemental Table S1.
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selection (Bochner et al., 1980) produced scarless mutations
of the targeted genes. For example, to obtain strain ΔgtrBTP1
(sMV386), which contains a deletion of the BTP1 prophage-
encoded gtrA* and the gtrC genes in D23580, the sequence
from 101 nt upstream of the start codon of the pseudogene
STMMW_03921 (gtrA*) to 15 nt downstream of the stop
codon of STMMW_03911 (gtrCBTP1) was first replaced with a
tetracycline cassette (amplified using oMV754/oMV755)
(Table S1). This sequence was, in turn, replaced with
oMV758 using the counter-selection method described.
These genes are located on the phage genome between the
phage TSP (TSP gene, STMMW_03901) and the phage–
host genome junction.
LPS extraction and visualization
Crude LPS extracts were prepared as described (Davies
et al., 2013). After running the samples on TSDS–PAGE
(Tricine-SDS–PAGE) gels, two methods were used for visu-
alization: either silver stain as described previously (Davies
et al., 2013) or Western blot. For Western blots, the samples
were transferred to polyvinylidene fluoride (PVDF) and
blocked with phosphate buffered saline with 0.1% Tween-20
(PBS-T) and 5% milk. The O4 serum from Statens Serum
Institute (Denmark) was used as primary antibody followed
by goat anti-rabbit IgG-HRP from Sigma (A0545). Millipore’s
Luminato Western HRP substrate was used for detection.
Membrane preparation and FLAG visualization
Vectors encoding for FLAG-tagged versions of the GtrCBTP1
protein were expressed in ΔgtrBTP1. Mid-exponential phase
cultures were induced with 100 μM ITPG and expression
allowed to occur for 30 minutes. Cells were then pelleted.
Whole cell lysate (WCL) samples were immediately boiled in
SDS buffer (0.1 m Tris–HCl, pH 6.8, 4% β-mercaptoethanol,
4% SDS, 20% glycerol). For crude membrane preparations,
the samples were resuspended in 1 ml PBS and subjected to
a freeze/thaw cycle (−80°C/RT) three times. Unbroken cells
were pelleted by centrifugation for 2 min (16,060× g) and the
supernatant transferred to a new Eppendorf. Membranes
were pelleted by centrifugation at 4°C for 1 hour (16,060× g).
The pellet was then resuspended in SDS buffer and boiled for
analysis by Western.
For protein detection, SDS–PAGE gels were used and then
transferred to PVDF. Blots were blocked with 5% milk PBS-T
and the primary antibody was Sigma’s Monoclonal ANTI-
FLAG M2 antibody produced in mouse (F3615). Secondary
antibody was goat anti-mouse IgG-HRP (Sigma; A0168).
Determining topology of BTP1 GtrC protein
The gtrC–phoA fusion vectors were introduced into E. coli
NEB5a and S. Typhimurium 4/74. After verification by colony
PCR using primers oMV1003 (CATGAAGCTTATTAATGC
AGCTGGCACGAC) and oMV1006 (CGTTGGGTGATC
TTTTTCGT) that strains contained the appropriate vectors,
colonies were patched onto LB agar plates containing
chloramphenicol and X-Phos (5-bromo-4-chloro-3-indolyl-
phosphate, 40 μg ml−1; Melford) for detection of the blue color
change.
RNA-seq
RNA-seq was performed on S. Typhimurium strain D23580
cultured in 16 environmental conditions: early exponential
phase, mid-exponential phase, late exponential phase, early
stationary phase, late stationary phase, 25°C, NaCl shock,
Bile shock, low Fe2+ shock, anaerobic shock, anaerobic
growth, oxygen shock, nonSPI2, InSPI2, peroxide shock
(InSPI2) and nitric oxide shock (InSPI2) as described (Kroger
et al., 2012; 2013). Sequence reads were mapped to the
S. Typhimurium D23580 genome (Genbank Accession
FN424405). The BTP1 gtrA* and gtrC TSSs were identified in
D23580 grown to ESP by dRNA-seq (Sharma et al., 2010).
Transcript per million (TPM) values for absolute levels of
gtrA* and gtrC gene expression were derived as described
previously (Kroger et al., 2013).
Preparation of phage-containing supernatants
BTP1 phage was prepared by pelleting overnight cultures of
D23580, removing the supernatant and treating with a few
drops of chloroform to kill any remaining bacteria. This pro-
duced phage titers with an average of 7 × 107 pfu ml−1. To
generate P22 supernatant for the experiments, a phage
lysate (50 μl at 104 pfu ml−1 of wild-type P22) was added to a
10 ml culture of exponential phase basal LT2 and growth
allowed to continue overnight. Bacteria were again pelleted,
the supernatant removed and treated with chloroform. This
produced a supernatant containing 3.5 × 1010 pfu ml−1.
Top agar phage assays
To create the lawn of bacteria, 100 μl of an overnight culture
was mixed with 3.5 ml of molten 0.7% agar, poured onto the
top of an LB agar plate and allowed to dry. Five microliters of
phage-containing supernatants or dilutions thereof were
spotted onto the bacterial lawns. The agar was touched with
the pipette tip to indicate where drops were placed. The drops
were allowed to dry before incubation overnight at 37°C.
Verifying O-antigen cleavage by BTP1 phage
To investigate O-antigen cleavage, phage-susceptible strains
were grown to overnight, pelleted and then resuspended in
the phage-containing supernatants containing chlorampheni-
col (100 μg ml−1) to prevent further bacterial growth and lysis
from the phage. Samples were incubated with the phage for
1 hour at 37°C before bacteria were pelleted and LPS pre-
pared as described.
Adsorption assay
BTP1 and P22 were diluted to a titer of 3.5 × 107 pfu ml−1.
Bacterial cells (approximately 3 × 108 cfu ml−1) were resus-
pended in the diluted phage (multiplicity of infection of 1:10)
and incubated at room temperature for 5 minutes. Bacteria
were then pelleted and the supernatant was removed. Dilu-
tions of the supernatant were used in the spot titer assay on
a lawn of basal LT2 to determine number of phage remaining
in the supernatant.
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